The Use of Thrombin Generation Assay in Detection of Central Line Related Thrombosis (CRT) in Critically Ill Patients

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

30 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-04-06

Study Completion Date

2025-04-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To study thrombin generation parameters in critically ill patients with and without central line related thrombosis (CRT).

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Global Hemostasis Monitoring by Using Sonoclot Signature in Traumatic Patients

NCT04100395

Study of Hemostatic Profile in Traumatic Patients

NOT_YET_RECRUITING

Thrombomodulin-modified Thrombin Generation Assay (TGA-TM) in Patients With Critical Infections

NCT04356144

Disseminated Intravascular Coagulation Critical Illness Sars-CoV2 +3 more

COMPLETED

Thromboelastogram During Total Knee Replacement

NCT02373969

Orthopedic Procedures, Tranexamic Acid

COMPLETED

Thrombin Generation in Liver Transplant Surgery

NCT04762550

Liver Transplantation Thrombin Hemostasis, Surgical +2 more

UNKNOWN

Thromboelastographic Guide for Blood Products in Cirrhotics

NCT02362178

Liver Cirrhosis Coagulation Disorder

COMPLETED PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Central Line Complication Thrombosis, Venous

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Thrombin generation assay

Thrombin generation parameters in patients receiving central catheter insertion

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age ≧ 18; AND
* Admitted to the mixed medical-surgical intensive care units of Queen Mary Hospital in Hong Kong; AND
* Clinically indicated for central catheter insertion, which includes central venous catheters and dialysis catheters; AND
* Expected to have the central catheter in place for at least 5 days in their ICU stay.

Exclusion Criteria

* Patients known to have active venous thromboembolism including deep venous thrombosis or pulmonary embolism;
* Patients known to have hypercoagulable states, e.g., hereditary thrombophilia, antiphospholipid syndrome; OR
* Patients with active solid organ or hematological malignancies; OR
* Patients already receiving therapeutic anticoagulation prior to study recruitment; OR
* Patients with thrombosis detected in the insertion site before central catheter insertion; OR
* Patients with a central venous catheter already in place prior to ICU admission; OR
* Patients admitted to the ICU for post-operative care; OR
* Patients admitted to the ICU for trauma care; OR
* Patients requiring extra-corporeal life support (ECLS); OR
* Patients with poor window or inaccessible for ultrasonographic examination; OR
* Pregnancy/post-partum within 6 weeks

Minimum Eligible Age

18 Years

Maximum Eligible Age

100 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No